SER
Serina Therapeutics·AMEX
--
--(--)
--
--(--)
5.08 / 10
Netural
Fund flow metrics score 7.41/10, revealing robust fund flow characteristics. Beneficial Small and Medium trends are challenged by problematic overall, block, Large, and Extra-large signals, indicating positive capital movement. Professional analyst opinion suggests overwhelmingly bullish analyst consensus, showing strong conviction. Distribution pattern: Strong Buy(100.0%) based on 1 research evaluations, supported by 2.75 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-08-28
InstitutionHC Wainwright & Co.
Times predicted2
Historical Win Rate50.0%
Is money flowing into or out of SER?
- SER holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.08/10 (Netural).
